WINTON GROUP Ltd Cuts Position in Pediatrix Medical Group, Inc. $MD

WINTON GROUP Ltd lessened its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 76.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 50,821 shares of the company’s stock after selling 164,275 shares during the quarter. WINTON GROUP Ltd’s holdings in Pediatrix Medical Group were worth $1,087,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Global Retirement Partners LLC grew its holdings in Pediatrix Medical Group by 68,250.0% in the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock worth $29,000 after purchasing an additional 1,365 shares during the period. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $33,000. Blue Trust Inc. purchased a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $37,000. TD Private Client Wealth LLC purchased a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $39,000. Finally, KBC Group NV purchased a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $65,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on MD shares. Mizuho set a $24.00 price target on shares of Pediatrix Medical Group in a report on Friday, May 8th. Jefferies Financial Group reiterated a “buy” rating and set a $27.00 price target on shares of Pediatrix Medical Group in a report on Monday, April 20th. Deutsche Bank Aktiengesellschaft set a $19.00 price target on shares of Pediatrix Medical Group in a report on Friday, February 20th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Friday, March 27th. Finally, UBS Group increased their price target on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $22.50.

Insiders Place Their Bets

In related news, Director Shirley A. Weis sold 36,028 shares of the stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total transaction of $855,665.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.80% of the stock is currently owned by company insiders.

Pediatrix Medical Group Trading Up 5.4%

NYSE:MD opened at $23.69 on Wednesday. The company’s 50 day moving average price is $22.24 and its 200-day moving average price is $21.69. Pediatrix Medical Group, Inc. has a 52 week low of $11.84 and a 52 week high of $24.99. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.45. The stock has a market cap of $1.95 billion, a price-to-earnings ratio of 11.50 and a beta of 0.69.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The company had revenue of $476.20 million for the quarter, compared to the consensus estimate of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.33 earnings per share. On average, equities research analysts forecast that Pediatrix Medical Group, Inc. will post 2.09 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.